Yes, depression is a recognized medical disorder. Formally called major depressive disorder, it is one of the most common mental health conditions in the world, affecting roughly 4% of the global population. It is classified as a disorder because it involves measurable changes in brain structure and function, follows a defined set of diagnostic criteria, and causes significant impairment in a person’s ability to carry out daily life.
What Makes Depression a Disorder, Not Just Sadness
Everyone feels sad after a job loss, a breakup, or the death of someone close. That kind of sadness is a normal emotional response, and it typically eases as circumstances change or time passes. Depression is different. It persists practically every day for at least two weeks, involves a cluster of symptoms beyond low mood, and disrupts sleep, appetite, thinking, and energy in ways that sadness alone does not.
The distinction matters because labeling depression as “just sadness” implies it can be resolved through willpower or positive thinking. A disorder, by definition, is a condition where normal functioning breaks down. In depression, that breakdown is both psychological and physical: the brain’s structure changes, the body’s stress system goes into overdrive, and basic functions like sleeping and eating become dysregulated.
How Depression Is Diagnosed
The diagnostic manual used by clinicians worldwide requires five or more specific symptoms to be present during the same two-week period. At least one of those symptoms must be either a persistently depressed mood or a noticeable loss of interest or pleasure in nearly all activities. The full list of recognized symptoms includes:
- Depressed mood most of the day, nearly every day, such as feeling sad, empty, or hopeless (in children and adolescents, this can show up as irritability)
- Loss of interest or pleasure in activities that used to be enjoyable
- Significant weight change of more than 5% of body weight in a month, or a clear shift in appetite
- Sleep disruption, either insomnia or sleeping far more than usual
- Observable physical restlessness or slowing down, noticeable to others
- Fatigue or loss of energy nearly every day
- Feelings of worthlessness or excessive guilt
- Difficulty thinking, concentrating, or making decisions
- Recurrent thoughts of death or suicide
These criteria are not arbitrary. They were developed through decades of clinical research to distinguish the disorder from temporary emotional responses. The two-week minimum, the requirement for multiple co-occurring symptoms, and the emphasis on functional impairment all serve as filters that separate clinical depression from ordinary unhappiness.
What Happens in the Brain
Brain imaging studies have documented structural changes in people with depression. Multiple regions show reduced gray matter volume, including areas involved in decision-making, memory, and emotional regulation. The hippocampus, a region critical for memory and stress regulation, is consistently smaller in depressed individuals compared to healthy controls. This shrinkage appears to result from prolonged exposure to stress hormones: the body’s stress response system stays activated, flooding the brain with cortisol, which damages hippocampal tissue over time.
Other affected areas include the prefrontal cortex (which helps with planning and impulse control), the thalamus (a relay station for sensory information), and the amygdala (involved in processing fear and emotional reactions). The prefrontal cortex becomes thinner, and the thalamus loses volume on both sides. Even the brain’s white matter, the wiring that connects different regions, shows disruptions in connectivity.
One encouraging finding is that these changes can partially reverse with treatment. Studies have shown that hippocampal volume increases after successful treatment, and gray matter in certain frontal regions recovers in patients who respond to therapy. This suggests the brain damage from depression is not necessarily permanent.
The Serotonin Question
For decades, depression was popularly explained as a “chemical imbalance,” specifically a shortage of serotonin in the brain. This idea drove the development of widely prescribed antidepressants designed to boost serotonin levels. However, a major systematic review published in Molecular Psychiatry found little consistent evidence that low serotonin causes depression. Earlier, smaller studies that seemed to support the theory were not confirmed by larger, more rigorous research.
This does not mean depression isn’t biological. It means the biology is more complex than a single chemical being too low. Depression involves changes across multiple brain circuits, stress hormone systems, inflammatory pathways, and neural connectivity patterns. The old “chemical imbalance” framing was an oversimplification, but the condition itself remains firmly rooted in measurable biological changes.
Physical Health Consequences
Depression is not just a brain condition. It carries serious consequences for the rest of the body, particularly the cardiovascular system. Among people with coronary artery disease, 20% to 40% also have depression, a rate far higher than in the general population. Having a heart attack combined with depression is associated with a two- to fourfold increase in the risk of subsequent cardiovascular events.
Several biological pathways explain this connection. Depression activates the body’s stress response system, raising cortisol levels, which in turn increases blood pressure, blood sugar, and triglycerides. People with major depression also have significantly higher levels of inflammatory markers in their blood. This chronic inflammation accelerates the buildup of arterial plaque and contributes to further brain changes that deepen the depression itself. The autonomic nervous system, which controls heart rate and other involuntary functions, also becomes dysregulated, reducing heart rate variability, an independent risk factor for heart disease.
Who It Affects
Depression is roughly 1.5 times more common in women than in men, with 6.9% of women affected compared to 4.6% of men. More than 10% of pregnant women and new mothers experience depression. Among adults over 70, the rate is 5.9%. These numbers represent conservative estimates, since many cases go undiagnosed, particularly in men, older adults, and people in regions with limited access to mental health care.
How It Responds to Treatment
The fact that depression responds to structured treatment is itself evidence of its status as a disorder. A meta-analysis comparing antidepressant medication to psychotherapy found no significant difference in short-term response and remission rates between the two approaches. Both produce meaningful improvement for a majority of patients. Psychotherapy showed a slight edge in longer-term outcomes, suggesting that the skills learned in therapy may offer more durable protection against relapse.
This treatment response also highlights something important about what depression is. Like other medical disorders, it follows recognizable patterns, responds to specific interventions, and has a known set of risk factors and biological markers. It is not a character flaw, a mood preference, or a sign of weakness. It is a condition with identifiable features, predictable consequences, and effective treatments.